The FDA has formally concluded that Golden Rice does not meet the appropriate nutritional requirements to make nutrient content claims. Golden Rice is a name given to rice plants that are genetically modified to produce beta-carotene in their grain. Event GR2E, the type of Golden Rice submitted to the FDA for approval, was developed by Syngenta; the Gates Foundation is currently funding further development of the variety. In countries where rice is a dietary staple, Vitamin A insufficiency is a serious problem, and many scientists and philanthropists hope that increasing the amount of beta-carotene in the diet will raise the amount of available Vitamin A. However, in a May 25 letter to the International Rice Research Institute, the FDA wrote that although this rice is no less safe in the food supply than ordinary rice, "the concentration of beta-carotene in [the] rice is too low to warrant a nutrient claim."